Zdrowie i gospodarka · 11/08/2026

FDA to Host Public Meeting on Reauthorization of Generic Drug User Fee Amendments

The Food and Drug Administration (FDA) is hosting a public meeting to discuss proposed recommendations for reauthorizing the Generic Drug User Fee Amendments (GDUFA) for fiscal years 2028 to 2032, with public comments due within 30 days